Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.
作者信息
Hamilton Robert J, Canil Christina, Shrem Noa Shani, Kuhathaas Kopika, Jiang Maria Di, Chung Peter, North Scott, Czaykowski Piotr, Hotte Sebastien, Winquist Eric, Kollmannsberger Christian, Aprikian Armen, Soulières Denis, Tyldesley Scott, So Alan I, Power Nicholas, Rendon Ricardo A, O'Malley Martin, Wood Lori
机构信息
Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada.
出版信息
Can Urol Assoc J. 2022 Jun;16(6):155-173. doi: 10.5489/cuaj.7945.
Abstract
摘要
相似文献
1
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.加拿大泌尿外科学会共识指南：睾丸生殖细胞癌的管理
Can Urol Assoc J. 2022 Jun;16(6):155-173. doi: 10.5489/cuaj.7945.
2
Qualitative Review of Clinical Guidelines for Medical and Surgical Management of Urolithiasis: Consensus and Controversy 2020.2020 年尿石症医学和外科治疗临床指南的定性评价：共识与争议
J Urol. 2021 Apr;205(4):999-1008. doi: 10.1097/JU.0000000000001478. Epub 2020 Dec 7.
3
Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.50岁及以上患者睾丸生殖细胞肿瘤的临床特征：日本泌尿外科学会癌症登记委员会的一项大规模研究
Int J Urol. 2017 Feb;24(2):124-128. doi: 10.1111/iju.13268. Epub 2016 Dec 4.
4
Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.2005年和2008年登记的睾丸癌患者的临床特征和肿瘤学结局：日本泌尿外科学会癌症登记委员会的首次大规模研究。
Int J Urol. 2014 Aug;21(8):S1-6. doi: 10.1111/iju.12441. Epub 2014 Apr 13.
5
6
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.欧洲生殖细胞癌诊断与治疗共识会议：欧洲生殖细胞癌共识小组（EGCCCG）第二次会议报告：第一部分
Eur Urol. 2008 Mar;53(3):478-96. doi: 10.1016/j.eururo.2007.12.024. Epub 2007 Dec 26.
7
Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.转移性睾丸癌的化疗：日本泌尿外科学会癌症登记委员会的首个全国性多机构研究。
Int J Urol. 2018 Aug;25(8):730-736. doi: 10.1111/iju.13720. Epub 2018 Jul 17.
8
Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumors.沙特肿瘤学会和沙特泌尿外科学会联合发布的睾丸生殖细胞肿瘤临床管理指南。
Urol Ann. 2016 Apr-Jun;8(2):141-5. doi: 10.4103/0974-7796.179240.
9
Modern Management of Testicular Cancer.睾丸癌的现代管理
Cancer Treat Res. 2018;175:273-308. doi: 10.1007/978-3-319-93339-9_13.
10
Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.生殖细胞肿瘤幸存者的泌尿系统第二恶性肿瘤：基于人群的分析。
Int Urol Nephrol. 2021 Mar;53(3):471-477. doi: 10.1007/s11255-020-02659-9. Epub 2020 Oct 14.
引用本文的文献
1
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors.晚期睾丸生殖细胞肿瘤化疗后接受睾丸切除术患者的病理和肿瘤学结果
Eur Urol Open Sci. 2025 Aug 7;79:69-78. doi: 10.1016/j.euros.2025.07.004. eCollection 2025 Sep.
2
Assessing complications from retroperitoneal lymph node dissection for testicular cancer in North America.评估北美地区睾丸癌腹膜后淋巴结清扫术的并发症
Can Urol Assoc J. 2025 Jun;19(6):167-172. doi: 10.5489/cuaj.9042.
3
Case report: A case with atypical presentation oftesticular choriocarcinoma.病例报告：一例睾丸绒毛膜癌的非典型表现病例。
Front Oncol. 2024 Jul 17;14:1223873. doi: 10.3389/fonc.2024.1223873. eCollection 2024.
4
Restricted access and advanced disease in post-pandemic testicular cancer.大流行后睾丸癌的受限治疗途径与晚期疾病
Can Urol Assoc J. 2024 Aug;18(8):262-267. doi: 10.5489/cuaj.8648.
5
Pure testicular choriocarcinoma, a rare and highly malignant subtype with challenging treatment: A case report and review of the literature.纯睾丸绒毛膜癌，一种罕见且高度恶性的亚型，治疗颇具挑战性：一例病例报告及文献综述
Mol Clin Oncol. 2023 Nov 15;20(1):1. doi: 10.3892/mco.2023.2699. eCollection 2024 Jan.
6
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.加拿大复发性睾丸生殖细胞肿瘤（GCT）患者挽救化疗的应用：一项全国性调查。
Curr Oncol. 2023 Jun 27;30(7):6166-6176. doi: 10.3390/curroncol30070458.
7
Accuracy of germ cell tumor histology and stage within a Canadian cancer registry.加拿大癌症登记处中生殖细胞肿瘤组织学和分期的准确性。
Can Urol Assoc J. 2023 Feb;17(2):44-48. doi: 10.5489/cuaj.8030.
8
Testicular cancer survivorship: Long-term toxicity and management.睾丸癌幸存者：长期毒性及管理
Can Urol Assoc J. 2022 Aug;16(8):257-272. doi: 10.5489/cuaj.8009.
9
Updated testicular cancer consensus guideline is a concise, balanced, and practical guide for clinicians.最新的睾丸癌共识指南是一份面向临床医生的简洁、平衡且实用的指南。
Can Urol Assoc J. 2022 Jun;16(6):174. doi: 10.5489/cuaj.7948.
本文引用的文献
1
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).影像学检查方法和频率在 I 期精原细胞瘤睾丸生殖细胞肿瘤监测中的应用：来自一项随机、III 期、非劣效性试验（TRISST）的结果。
J Clin Oncol. 2022 Aug 1;40(22):2468-2478. doi: 10.1200/JCO.21.01199. Epub 2022 Mar 17.
2
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.预测转移性非精原细胞瘤生殖细胞肿瘤（NSGCT）男性患者的结局：国际生殖细胞肿瘤协作组更新联盟的结果。
J Clin Oncol. 2021 May 10;39(14):1563-1574. doi: 10.1200/JCO.20.03296. Epub 2021 Apr 6.
3
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.转移性精原细胞瘤的生存和新预后因素：IGCCCG 更新联盟的研究结果。
J Clin Oncol. 2021 May 10;39(14):1553-1562. doi: 10.1200/JCO.20.03292. Epub 2021 Mar 17.
4
Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach.晚期精原细胞瘤化疗后残留肿块的放射治疗：基于氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的风险适应方法。
Clin Oncol (R Coll Radiol). 2021 Jul;33(7):e315-e321. doi: 10.1016/j.clon.2021.01.009. Epub 2021 Feb 16.
5
Contemporary trends in management of stage 1 seminoma.一期精原细胞瘤的当代管理趋势
Urol Oncol. 2021 Apr;39(4):240.e1-240.e8. doi: 10.1016/j.urolonc.2020.08.025. Epub 2021 Feb 16.
6
Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment.通过早期病例确定，在大型综合医疗服务系统中实施多学科专家睾丸癌肿瘤委员会。
JCO Clin Cancer Inform. 2021 Feb;5:187-193. doi: 10.1200/CCI.20.00114.
7
Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest.切除的胸部转移性非精原细胞瘤的病理一致性。
J Thorac Cardiovasc Surg. 2021 Mar;161(3):856-868.e1. doi: 10.1016/j.jtcvs.2020.10.158. Epub 2020 Nov 30.
8
Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.早期睾丸生殖细胞肿瘤的管理：监测、初级化疗、放疗和腹膜后淋巴结清扫的比较效果：系统评价。
J Urol. 2021 Feb;205(2):370-382. doi: 10.1097/JU.0000000000001364. Epub 2020 Sep 11.
9
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.转移性非精原细胞瘤性生殖细胞肿瘤化疗后完全缓解患者的长期监测
Eur Urol Oncol. 2021 Apr;4(2):289-296. doi: 10.1016/j.euo.2020.08.007. Epub 2020 Sep 6.
10
Discrepancy in pathology reports upon second review of radical orchiectomy specimens for testicular germ cell tumors.对睾丸生殖细胞肿瘤根治性睾丸切除术标本进行二次复查时病理报告存在差异。
Can Urol Assoc J. 2020 Dec;14(12):411-415. doi: 10.5489/cuaj.6481.
Zotero 插件